Gregory Dyas

Title: Gregory Dyas: Innovator in Ferroportin Antibodies

Introduction

Gregory Dyas is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target ferroportin, a protein involved in iron homeostasis. With a total of 2 patents, Dyas is recognized for his innovative approaches to treating disorders related to iron regulation.

Latest Patents

Dyas's latest patents focus on ferroportin antibodies and their methods of use. These compositions are designed to treat disorders of iron homeostasis. More specifically, they include anti-ferroportin antibodies, compositions containing such antibodies, corresponding nucleic acids, vectors, and host cells. The methods for making these antibodies are also detailed in his patents, showcasing his commitment to advancing medical treatments.

Career Highlights

Gregory Dyas is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to collaborate with other talented professionals in the field. His innovative research has the potential to impact the treatment of various iron-related disorders significantly.

Collaborations

Some of Dyas's coworkers include Tara Arvedson and James Rottman. Their collaborative efforts contribute to the advancement of research and development in biotechnology.

Conclusion

Gregory Dyas is a prominent inventor whose work on ferroportin antibodies is paving the way for new treatments in iron homeostasis disorders. His contributions to biotechnology are noteworthy and reflect his dedication to innovation in the field.